UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Burt Wealth Advisors

Posted by Defense World Staff on Jun 25th, 2023

Burt Wealth Advisors reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,733 shares of the healthcare conglomerate’s stock after selling 246 shares during the quarter. UnitedHealth Group makes up 2.6% of Burt Wealth Advisors’ portfolio, making the stock its 14th biggest holding. Burt Wealth Advisors’ holdings in UnitedHealth Group were worth $8,380,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Chelsea Counsel Co. acquired a new stake in UnitedHealth Group during the fourth quarter worth about $27,000. Freedom Wealth Alliance LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $31,000. Investors Research Corp increased its stake in UnitedHealth Group by 51.1% during the fourth quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock worth $38,000 after acquiring an additional 24 shares during the last quarter. Legend Financial Advisors Inc. acquired a new stake in UnitedHealth Group during the third quarter worth about $37,000. Finally, Bourgeon Capital Management LLC boosted its position in shares of UnitedHealth Group by 192.3% in the fourth quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock worth $40,000 after buying an additional 50 shares during the period. 92.61% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. StockNews.com downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Truist Financial decreased their target price on UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $627.00 to $564.00 in a research report on Friday, June 16th. TD Cowen reduced their price target on UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a report on Monday, April 17th. Finally, Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Monday, April 17th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $592.68.

UnitedHealth Group Price Performance

UNH stock opened at $477.00 on Friday. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $558.10. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $444.10 billion, a P/E ratio of 21.81, a PEG ratio of 1.39 and a beta of 0.68. The company has a fifty day moving average price of $485.19 and a 200-day moving average price of $492.31.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, beating analysts’ consensus estimates of $6.24 by $0.02. The company had revenue of $91.93 billion for the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. UnitedHealth Group’s revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the company posted $5.49 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 24.86 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th will be issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Thursday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s dividend payout ratio (DPR) is 34.39%.

Insiders Place Their Bets

In related news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,684 shares of the company’s stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $488.46, for a total value of $822,566.64. Following the completion of the transaction, the executive vice president now directly owns 8,675 shares in the company, valued at $4,237,390.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The disclosure for this sale can be found here. Insiders have sold a total of 8,852 shares of company stock valued at $4,313,962 in the last quarter. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.